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ABSTRACT 
Glycine receptor subunit alpha2 and alpha3 high-affinity variants, of which the subjacent amino acid 
substitutions issue from C-to-U RNA editing, are thought to influence tonic inhibition and pathophysiology. 
In light of the detection of GLRA3 NM_006529:r.1157C>U and GLRA2 NM_002063:r.1416C>U 
exchanges in hippocampus explants of temporal lobe epilepsy patients, we now examine the healthy 
situation, and relate it to the epileptic situation by ascertaining controls in a legitimate re-analysis. The 
GLRA2 and GLRA3 editing events that would ultimately result in a glycine receptor with the increased 
affinity occur in post-mortem, non-epileptic hippocampus. Most notably, their relative amounts do not 
significantly differ from those in increasedly damaged hippocampus explants. Whereas curbed relative 
amounts in epileptic explants without cell loss come out statistically significant. Local sequence alignment 
reveals invariant sequence stretches consistent in GLRA2/GLRA3 and other edited transcripts that 
coincide with known APOB sequence elements. Concerning the essential mooring element, 
GLRA2/GLRA3 comply strictly only with the motif’s 5’ part. While this lack of canonical mooring elements, 
and uncertain action of the famous deaminase APOBEC1, suggest a specific regulation of GLRA2/GLRA3 
editing, its reduction in less-damaged epileptic hippocampus could be attributed to anomalous epileptic 
neurogenesis. 
 
INTRODUCTION 
Epilepsy, a major neurological disorder, is associated with a large number of syndromes all involving 
unpredictable seizures. About 36 percent of epileptic patients have inborn or acquired resistances to 
antiepileptic pharmaceuticals. Neurosurgery of an identified epileptic focus can provide remedy from 
seizures for highly affected patients, but novel medications are still sought for [Mohanraj and Brodie, 2006; 
Kwan and Brodie, 2000; Wood, 2011]. 
Typically, epileptogenic activities at the hippocampus would be balanced by its inhibitory neurons. A 
disruption of hippocampus interneurons can contribute to excitatory-inhibitory imbalance within the 
epileptic network [Reyes 2006; Fröhlich et al., 2006; Dudek and Sutula, 2007; Nadler, 2003]. The glycine 
receptor (GlyR) is an inhibitory ligand-gated ion channel, like the GABA(A) receptor, although less 
abundant. It consists of an extracellular ligand binding domain, a transmembrane chloride pore, formed by 
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a pentameric setup of ligand-binding alpha subunits (GLRA1, GLRA2, GLRA3, also referred to as: GlyR 
alpha1, alpha2, alpha3) with the structuring beta subunit, and a rather variable intracellular domain 
[Langosch et al., 1990; Betz et al., 1999; Chattipakorn and Mc Mahon, 2002; Keck et al., 2008]. GlyR is 
located inter alia in the hippocampus, in interneurons, at synaptic sites, as well as extrasynaptically [Avila 
et al., 2013]. Modulation of excitatory postsynaptic potentials and inhibition in GABAergic interneurons via 
GlyR [Song et al., 2006] contributes to glycinergic tonic inhibition [Zhang et al., 2008; Xu and Gong, 2010]. 
Previously, a variant cDNA of the glycine receptor alpha3 subunit (Glra3 NM_053724:r.701C>U) that 
encodes a certain proline-to-leucine exchange (GLRA3 NP_446176:p.Pro234Leu; colloquially referred to 
as: GlyR alpha3 P185L) was described. The exchange alters a loop at the bottom of the ligand-binding 
domain adjacent to the brink of the pore. The variant subunit displays an increased apparent affinity for its 
ligand, likely enabling a high-affinity GlyR that responds to ambient glycine [Meier et al., 2005; Ogino et 
al., 2007; Du et al., 2015; Sherwin, 1999]. The corresponding substitution Glra2 NM_012568:r.1207C>U 
causes another high-affinity alpha subunit (GLRA2 NP_036700:p.Pro219Leu; colloquially referred to as: 
GlyR alpha2 P192L). In an analysis of hippocampus explants of pharmacoresistant temporal lobe epilepsy 
(TLE) patients, it was reported that the relative amounts of the same variations in humans, GLRA2 
NM_002063:r.1416C>U and GLRA3 NM_006529:r.1157C>U (referred to as: GlyR alpha2-C575U and 
GlyR alpha3-C554U), increase under severe sclerotic cell loss and secondary generalized tonic-clonic 
seizure (grand mal) frequency. However, no information on the non-epileptic state was given. Genomic 
GLRA2 DNA of patients carried no corresponding point mutation or single nucleotide polymorphism (SNP) 
of [Eichler et al., 2008]. This supported the assumption of C-to-U RNA editing being responsible for the 
variants’ origin, deduced from a sequence stretch similar to a spacer sequence downstream of Glra3 
NM_053724:r.701C>U [Meier et al., 2005]. 
 
In C-to-U-edited apolipoprotein B mRNA (APOB), the spacer and the mooring sequence elements are 
constituents of a stem loop that exposes a cytidine to enzymatic deamination. Several additional 
sequence elements, most important for APOB editing, flank the deaminated position, from 60 nucleotides 
upstream to 160 nucleotides downstream [Hersberger et al., 1999; Maris et al., 2005; Shah et al., 1991; 
Backus and Smith, 1992; Driscoll et al., 1993; Hersberger and Innerarity, 1998; Sowden et al., 1998]. Two 
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prominent proteins bind the APOB transcript: The cytidine deaminase apolipoprotein B editing complex 
(APOBEC1), and the RNA-binding protein Apobec complementary factor (ACF). In the liver, APOBEC1 
deaminates a cytidine residue in the APOB transcript to a uridine residue, resulting in two protein variants, 
both physiologically relevant in energy metabolism [Teng et al., 1993; Lellek et al., 2000; Mehta et al., 
2000; Henderson et al., 2001; Chester et al., 2000]. Until recently, few further C-to-U-edited transcripts 
had been characterized [Skuse et al., 1996; Wang et al., 2004]. Nowadays numerous, murine targets of 
APO1 have been described, leading to further characterization of the mooring motif [Rosenberg et al., 
2012]. 
 
In our study post-mortem hippocampus material is used to display the healthy situation of C-to-U edited 
human GLRA2 and GLRA3. By doing this, control groups are generated that augment the study 
mentioned above on epileptic hippocampus explants [Eichler et al., 2008]. Consequently, these results are 
presented alongside a legitimate re-analysis of that former series of experiments, adjusting the previous 
explanatory view on the relation of editing levels and course of disease. In addition, we describe the 
situation of several sequence elements and features most crucial to RNA editing in this matter. 
 
MATERIALS AND METHODS 
Quantitative cloning analysis 
Post-mortem hippocampus tissue was obtained at autopsy from three individuals whose deaths had 
occurred out of hospital and were attributable to different natural and unnatural causes. Pre-existing 
pathologic conditions of the central nervous system were ruled out by histology, and underlying 
intoxications were ruled out by toxicological analysis. Specimen were comparable to the TLE 
neurosurgery explant series in terms of their local origin, age, and fixativeless procession [Eichler et al., 
2008], except for their post-mortem delays that exceeded the surgery explant delays for up to five hours. 
RNA was isolated with Trizol (Thermo Fisher, Waltham, MA). Additionally, a commercially available 
pooled hippocampus RNA (provided by R. J. Harvey, London) was used [Rees et al., 2006]. Cloning 
assays to quantify GLRA2 NM_002063:r.1416C>U and GLRA3 NM_006529:r.1157C>U were performed 
in the identical setup described previously [Meier et al., 2005; Eichler et al., 2008]. Briefly, PCR used 
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degenerated mismatch primers that introduce restriction sites only into templates with the respective 
nucleotide exchanges. After restriction endonuclease digestion, insertion into custom vectors, 
transformation, and determination of confirmed-positive colony numbers, the percentage of clones with a 
variant insert proportionate to the total amount of control clones reflected the relative amount of edited 
GLRA2/GLRA3 mRNA for each sample. 
Instead of averaging triplicate measurements for one specimen and grouping the averages, all individual 
data points of each condition were grouped collectively. In post-mortem GLRA2 measurements, thirteen 
out of fifteen individual data points represent the three matched individuals, while two out of fifteen data 
points represent the twenty pooled individuals. In the post-mortem GLRA3, six out of eight data points 
represent the three matched individuals, while two out of eight data points represent the twenty pooled 
individuals. The approach allowed re-analysing the dataset from formerly examined series of epilepsy 
surgery explants from pharmacoresistant TLE [Eichler et al., 2008], including also several specimen that 
had not yielded triplicate data. For comparability, general data grouping was retained. Seven individuals of 
the group of patients explants without marked hippocampal cell loss and sclerosis are represented by 29 
data points in GLRA2 measurements and by eighteen data points in GLRA3. In the group with increased 
damages attributable to sclerosis, cell loss, and frequent grand mal, the eighteen individuals are 
represented by 57 data points in GLRA2 measurements, and by 53 data points in GLRA3. Mann-Whitney 
testing was performed with OriginPro 8G (OriginLab, Northampton, MA), with a p value less than 0.05 
considered as statistically significant. 
 
Database co-expression approach 
Conserved domain database (CDD) entries [Marchler-Bauer et al., 2015] with cytidine deaminase 
domains were examined for co-expression with GlyR in hippocampus. Geneatlas datasets in BioGPS 
genereports were used to check for human brain expression of any genes of interest [Wu et al. 2009]. 
Murine in-situ-hybridization data publicly available from the Allen brain atlas [Lein et al., 2007] was used to 
compare the hippocampal expression patterns of the candidate deaminase CDADC1 and of GLRA2 and 
GLRA3. GLRA4 expression data served as negative control. Of each set of images (antisense probe, 
sagittal plane, experiment numbers: 70525807, CDADC1; 71587739, GLRA2; 70723453, GLRA3; 
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70724744, GLRA4) consisting of nineteen to twenty sections, approx. the sixth (for the parasagittal plane) 
and thirteenth section (for the midsagittal plane) were selected, depending on pattern/plane visibility. To 
visualise the expression data in greyscale, the ISH and expression layers were transferred into the GIMP 
2.8 raster graphics editor. Relevant expression domains were cropped. ISH layers were greyscaled, and 
brightness was set to +50. Expression layers were inverted, colour white was changed into transparency, 
and all remaining colour information was changed into black. Then both layers were merged. 
 
Sequence comparison 
Nucleotide sequences of C-to-U edited transcripts were traced from their respective genebank entries. 
Sequence conservation not revealed by conventional comparison matrices was exposed via manual 
alignment with GeneDoc [Nicholas and Nicholas, 1997]. Hyphens indicate introduced gaps. Shading 
mode was set to conserved, primary conservation (black shading, upper case consensus line) was set to 
100 percent, secondary conservation (dark grey shading, lower case consensus line) was set to 75 
percent and tertiary conservation (light grey shading, not marked in consensus line) was set to 40 percent. 
 
RESULTS 
GLRA2 and GLRA3 editing in hippocampus 
Pronounced relative amounts of the C-to-U editing events GLRA2 NM_002063:r.1416C>U and GLRA3 
NM_006529:r.1157C>U occur in post-mortem hippocampus RNA (see Fig. 1), detected via quantitative 
cloning assays targeting the respective cDNA nucleotide exchanges. 
Conjoint with equivalently re-analysed epilepsy surgery explants, the post-mortem series serves as non-
epileptic controls. These data show comparatively smaller relative amounts of edited GLRA2/GLRA3 in 
explants without hippocampal cell loss than in both the post-mortem control group and the group of 
explants with marked cell loss and grand mal frequency. The relative amounts of the two latter groups do 
not show significant differences (see ‘n. s.’ in Fig. 1). The low of editing in the former group is statistically 
significant (asterisks in Fig. 1), attenuated in GLRA2, and more intensive in GLRA3. 
 
Consistent stretches of invariant nucleotides, shared in GLRA2 and GLRA3 and other C-to-U-edited 
7 
 
transcripts 
Using manual alignment of sequence subsections flanking the edited nucleotide, consistent sequence 
stretches of invariant and highly invariant nucleotides, shared between GLRA2/GLRA3 as well as other C-
to-U-edited transcripts, and distributed in an interlaced pattern, were identified (see Fig. 2A): Viewed from 
5’ to 3’, these consistent stretches appear in the “A....ug.....AA......UG” stretch located at marker position 
1-23, the “cAa.........UG....a” stretch located at position 48-66, the “Ga.u.a” stretch at position 80-85, and 
the “C.....a.uu......uga” stretch located around position 101-118 in Fig. 2A), each formed of up to seven 
shared nucleotides. Another, more weakly shared, stretch, that is not consistent in each inspected 
transcript, is “c.ga..tata”, located at alignment position 63-80. Within the consistent stretches, variant or 
unique nucleotides appear, up to five or nine in number. Outside of the consistent stretches, variant and 
unique nucleotides are present more often and in longer succession (see alignment positions 24-47, 86-
100, and 130-154 in Fig 2A). 
The consistencies agree with sequence elements that have been demonstrated to be highly relevant for 
APOB editing: The “A....ug.....AA......UG” stretch resides directly at the 5’ border of the upstream A-rich 
element determined in APOB; the “Ga.u.a” stretch encloses the regulator sequence element; the 
“C.....a.uu......uga” stretch comprises the well-known spacer and in parts the mooring element. GlyR 
alpha2 and alpha3 subunit transcript sequences lack most of the 3’ and mid parts of the mooring motif, 
and they supplant it at position 120-124. In the 5’ part they conform very well to the motif. Downstream of 
the mooring, another A-rich stretch is shared in all inspected transcripts. The 3’ untranslated region (UTR) 
of rat Glra3 features an almost exact mooring sequence, located 1121 nucleotides downstream of the 
edited cytidine (see Fig. 2B). 
 
Concurrent features of CDADC1 
Apparent from database queries, cytidine deaminase domain containing 1 (CDADC1) possesses two 
cl00269 cytidine deaminase-like superfamily domains that resemble the catalytic domain of APOBEC1 
(see Fig. 3A and 3B). In murine hippocampus, there are overlaps in the gene expression patterns of 
Cdadc1 in dentate gyrus and in CA1-CA3 with those of Glra2, as well as in hilus with Glra3 (see Fig. 3C). 
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DISCUSSION 
Lately, one could follow a controversial debate over the physiologic extent of RNA editing, highlighting 
once again the high level of detail necessary for its examination [Li et al., 2011; Chakravarti, 2011; 
Kleinman and Majewski, 2012; Wang et al., 2014]. Also the case of C-to-U-editing of GlyR alpha subunit 
RNA deserves thorough interpretation. After the original description, another study added very well to the 
feasible accuracy of detecting Glra3 NM_053724:r.701C>U, whereas it was omitted to detect native, 
edited, Glra3 transcripts [Meier et al., 2005; Nakae et al., 2008]. Later on, it was assumed that increased 
levels of editing were a specific attribute of the diseased, epileptic state [Eichler et al., 2008; Winkelmann 
et al., 2014]. 
The presented work describes for the first time distinct GLRA2 NM_002063:r.1416C>U and GLRA3 
NM_006529:r.1157C>U RNA editing events in healthy hippocampus using heterogenous post-mortem 
material. This finding then enabled our legitimate re-analysis of the previous series of experiments with 
the post-mortem material integrated as necessary non-epileptic controls, showing the particular decline of 
the relative amounts of edited GLRA2 and GLRA3 in the lesser-damaged epileptic hippocampus. This is a 
relevant result and refines that very assessment of how epileptic damages and editing levels are 
associated in pharmacoresistant TLE. 
 
Ectopic granule neurons or anomalous latency phase neurogenesis [Scharfman and Pierce, 2012; Parent 
et al., 2006; Parent et al., 1997] might provide one explanation for the pathological decrease in editing, 
and its different extent in the two subunit transcripts. Newly generated cells in the epileptic hippocampus 
can arise from more than one source area, and can migrate in varying amounts towards DG and CA1/CA2 
(the main expression domains of Glra2), as well as towards CA4 [Crespel et al., 2005] (the main region of 
Glra3 gene expression). In general, young neurons show less GlyR gene expression [Aroeira et al., 2011], 
and rodent prenatal hippocampal neurons seldom display pronounced Glra2/Glra3 C-to-U events 
(unpublished observation). Accordingly a ‘dilution’ of hippocampal cells by aberrant, immature cells could 
be one possible cause of the apparent drop in editing. Sclerotic cell loss [Blümcke et al., 2000; Zhu et al., 
1997; Blümcke et al., 2009] in the increased-damage explants group is not accompanied by significant 
reductions of C-to-U levels, compared to the non-epileptic post-mortem situation, yet they could still play a 
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role in the very slight reduction visible in this group. 
 
Detecting editing events in PCR amplicons does not directly prove the existence of functional increased-
affinity GlyR, but it tracks the activity of its deaminase, whose identity is another open problem. We 
present properties of CDADC1 that resemble those of the important cytidine deaminase APOBEC1 and of 
the concerned glycine receptor alpha subunits in hippocampus. In brain, gene expression of APOBEC1 is 
relatively meagre (publicly available microarray data) and recent studies reported only very vaguely on its 
native expression in brain tissue [Gee et al., 2011; Guo a. 2011; Papavasiliou et al., 2014]. Despite this 
apparent absence, silencing of glycinergic currents following steric inhibition of Apobec cytidine 
deaminases with a cytidine analogue had been reported [Meier et al., 2005]. Although the drug indeed can 
affect Apobec-family deaminases, it should be argued that administering the cytidine analogue without 
sequence context could have influenced channel gating in different ways [Rausch et al., 2009; Wedekind 
and Smith, 2012; Seifert et al., 2011; Zong et al., 2012]. 
 
To determine the extent of the common sequence basis of well-characterized APOBEC1-mediated C-to-U 
editing with that of GLRA2/GLRA3, manual alignment of various cDNA sequences with documented 
C-to-U editing events was performed. The found consistent stretches of invariant nucleotides accord with 
the upstream A-rich, the regulator, and the spacer elements, which are very well characterized in Apob 
[Shah et al., 1991; Backus and Smith, 1992; Driscoll et al., 1993; Hersberger and Innerarity, 1998; 
Sowden et al., 1998; Hersberger et al., 1999]. Discovery of additional, murine targets of APOBEC1 had 
led to further characterization of the mooring element [Rosenberg et al., 2012], but GlyR alpha2 and 
alpha3 transcript sequences fit this motif only in its 5’ part (it should be noted that the seemingly merged 
spacer and mooring elements of Serinc1 also deviate from the motif). Whether the conventional mooring 
in the 3’ untranslated region (UTR) of rat Glra3 corresponds to a respective C-to-U event is not known. 
Many of the additional murine transcripts carry their edited positions and their mooring elements in the 3’ 
UTR [Rosenberg et al., 2012], whereas in transcripts encoding GlyR alpha2 and alpha3 the edited 
positions and their adjacent 3’ deviant mooring elements are present in the open reading frame (ORF). A 
mooring sequence in an UTR can understandably comply to the motif more closely than in an ORF, where 
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mandatory compliance to codon information restricts sequence variability. 
In this regard, two known synonymous SNP’s in the inspected sequence section of GLRA3 should be 
mentioned: Rs140655344 shifts a glutamate codon from GAG to GAA, making the A-rich region more A-
rich. Rs41279513 can appear in the spacer, changing a glutamine codon from CAG to CAA, creating a 
spacer element identical to that of APOB. While invariant nucleotides could participate in secondary 
structures that capacitate binding or efficacy of a deaminase complex [Hersberger et al., 1999; Maris et 
al., 2005], deviations from the established elements could possibly even condition an unusual deaminase 
setup. 
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FIGURE 1 
Occurrence of GLRA2/GLRA3 C-to-U RNA editing in healthy post-mortem hippocampus is compared with 
re-analysed, corresponding data obtained from surgical explants of pharmacoresistant epilepsy patients 
[Eichler et al., 2008]. The relative amounts of edited GLRA2/GLRA3 (% edited) in healthy post-mortem 
hippocampus versus the epileptic situation with increased damage (attributable to sclerotic cell loss and 
frequent grand mal) do not differ significantly. By contrast, the low relative amounts in epileptic explants 
without hippocampal cell loss and marked sclerosis are significant. 
 
 
FIGURE 2 
A. Invariant nucleotides of GLRA2/3 shared with other C-to-U edited transcripts agree with known 
sequence elements. Rectangular bars on top of the alignment indicate consistent stretches of invariant 
nucleotides. Below, hatched bars indicate weakly shared stretches, which are not consistent with all 
inspected transcripts (main diagonal hatching for consistencies in GLRA2/GLRA3 and few other 
transcripts, but not with APOB; anti-diagonal hatching indicates consistencies in APOB and other 
transcripts, but not with GLRA2/GLRA3; and chequered hatching for consistencies in GLRA2/GLRA3 and 
APOB, but not with every single one of the others). APOB sequence elements [Shah et al., 1991; Backus 
and Smith, 1992; Driscoll et al., 1993; Hersberger and Innerarity, 1998; Sowden et al., 1998; Hersberger 
et al., 1999] are indicated with lines at the bottom; mooring elements are indicated with hooked lines. 
Transcript prefixes indicate species. Deaminated cytidine at alignment position 100. 
B. The 3’ UTR of rat Glra3 (genebank entry M55250) contains a sequence nearly identical to the mooring 
element of Apob. Motif sequence from [Rosenberg et al., 2012]. 
 
FIGURE 3: 
A. Domain structure of CDADC1 compared with those of two paradigmatic Apobec family members. 
CDADC1 contains two domains that match the zinc-binding region of the cl00269 cytidine deaminase-like 
superfamily, which also the catalytic domain of the C-to-U deaminase APOBEC1 belongs to. Modified 
after [Marchler-Bauer et al., 2015]. 
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B. Sequence alignment of the similarities between CDADC1 and APOBEC1, within the cl00269 
superfamily of cytidine and deoxycytidylate deaminases. The two deaminase domains of CDADC1 are 
abbreviated as dom1 and dom2. cd01286: Deoxycytidylate (dCMP) deaminase domain; pfam08210: 
APOBEC-like N-terminal (catalytic) domain; cd01283: Cytidine deaminase zinc-binding domain. Modified 
after [Marchler-Bauer et al., 2015]. 
C. Murine hippocampus gene expression patterns of Cdadc1 notably overlap with those of Glra2 in 
pyramidal layer of CA1-3 and in granule cell layer of dentate gyrus, with those of Glra3 in hilus or 
polymorph layer of dentate gyrus. Glra4 as negative control. Marker bars: parasagittal plane 500 µm; 
midsagittal plane 1000 µm. Modified after [Lein et al., 2007]. 
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